Free Trial

Medifast (MED) News Today

Medifast logo
$12.60 -0.32 (-2.48%)
As of 10:05 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Medifast, Inc. stock logo
Medifast, Inc. (NYSE:MED) Shares Sold by Quinn Opportunity Partners LLC
Quinn Opportunity Partners LLC cut its position in Medifast, Inc. (NYSE:MED - Free Report) by 38.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 71,607 shares of the specialty retailer's stock after selling
Medifast, Inc. stock logo
Medifast, Inc. (NYSE:MED) Shares Purchased by Federated Hermes Inc.
Federated Hermes Inc. increased its stake in shares of Medifast, Inc. (NYSE:MED - Free Report) by 28.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 279,473 shares of the specialty retailer's stock after buying an
Medifast, Inc. stock logo
Arrowstreet Capital Limited Partnership Sells 180,332 Shares of Medifast, Inc. (NYSE:MED)
Arrowstreet Capital Limited Partnership lessened its stake in Medifast, Inc. (NYSE:MED - Free Report) by 77.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 51,396 shares of the specialty retailer's stock after selling 180
Medifast, Inc. stock logo
Medifast, Inc. (NYSE:MED) Shares Sold by Trexquant Investment LP
Trexquant Investment LP trimmed its position in Medifast, Inc. (NYSE:MED - Free Report) by 44.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 58,304 shares of the specialty retailer's stock after selling 47,206 shares during the peri
Medifast, Inc. stock logo
Prudential Financial Inc. Lowers Holdings in Medifast, Inc. (NYSE:MED)
Prudential Financial Inc. lowered its position in shares of Medifast, Inc. (NYSE:MED - Free Report) by 37.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 46,485 shares of the specialty retailer's stock aft
3 Reasons MED is Risky and 1 Stock to Buy Instead
Medifast, Inc. stock logo
Landscape Capital Management L.L.C. Buys New Stake in Medifast, Inc. (NYSE:MED)
Landscape Capital Management L.L.C. purchased a new position in shares of Medifast, Inc. (NYSE:MED - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 32,734 shares of the specialty retailer's stock, valued a
Medifast, Inc. stock logo
Charles Schwab Investment Management Inc. Sells 34,098 Shares of Medifast, Inc. (NYSE:MED)
Charles Schwab Investment Management Inc. trimmed its stake in Medifast, Inc. (NYSE:MED - Free Report) by 23.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 114,138 shares of the specialty retailer's stock after se
Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect
Medifast management to meet virtually with Stephens
Medifast, Inc. stock logo
Amundi Invests $374,000 in Medifast, Inc. (NYSE:MED)
Amundi acquired a new position in Medifast, Inc. (NYSE:MED - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 21,215 shares of the specialty retailer's stock, valued at approximat
Medifast, Inc. stock logo
Zacks Research Has Strong Estimate for Medifast Q1 Earnings
Medifast, Inc. (NYSE:MED - Free Report) - Research analysts at Zacks Research lifted their Q1 2025 EPS estimates for Medifast in a research note issued on Monday, March 10th. Zacks Research analyst R. Department now anticipates that the specialty retailer will post earnings of ($0.07) per share f
Medifast, Inc. stock logo
Zacks Research Issues Negative Outlook for Medifast Earnings
Medifast, Inc. (NYSE:MED - Free Report) - Research analysts at Zacks Research cut their Q2 2025 EPS estimates for Medifast in a note issued to investors on Monday, March 10th. Zacks Research analyst R. Department now forecasts that the specialty retailer will post earnings per share of $0.24 for
Medifast, Inc. stock logo
110,000 Shares in Medifast, Inc. (NYSE:MED) Bought by Prescott Group Capital Management L.L.C.
Prescott Group Capital Management L.L.C. purchased a new stake in shares of Medifast, Inc. (NYSE:MED - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 110,000 shares of the specialty retai
Medifast, Inc. stock logo
What is DA Davidson's Forecast for Medifast Q1 Earnings?
Medifast, Inc. (NYSE:MED - Free Report) - Equities research analysts at DA Davidson issued their Q1 2025 earnings per share (EPS) estimates for shares of Medifast in a report issued on Thursday, February 20th. DA Davidson analyst L. Weiser anticipates that the specialty retailer will post earning
Medifast, Inc. stock logo
DA Davidson Cuts Medifast (NYSE:MED) Price Target to $16.50
DA Davidson cut their price objective on Medifast from $17.00 to $16.50 and set a "neutral" rating for the company in a research report on Wednesday.
Medifast Full Year 2024 Earnings: EPS Beats Expectations
Q4 2024 Medifast Inc Earnings Call
Medifast sees Q1 revenue $100M-$120M
Medifast reports Q4 adjusted EPS 10c vs. $1.09 last year
Medifast, Inc. stock logo
Medifast (NYSE:MED) Posts Earnings Results, Beats Estimates By $0.26 EPS
Medifast (NYSE:MED - Get Free Report) announced its earnings results on Tuesday. The specialty retailer reported $0.10 EPS for the quarter, topping the consensus estimate of ($0.16) by $0.26. Medifast had a return on equity of 15.98% and a net margin of 1.09%.
Medifast, Inc. stock logo
Medifast (NYSE:MED) Issues Q1 2025 Earnings Guidance
Medifast (NYSE:MED) updated its first quarter 2025 earnings guidance. The company provided EPS guidance of -0.500-0.000 for the period, compared to the consensus estimate of -0.190. The company also issued revenue guidance of $100.0 millionillion-$120.0 millionillion, compared to the consensus estimate of $130.8 millionillion.
Q4 2024 Medifast Inc Earnings Call Transcript
Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript
Medifast, Inc. stock logo
Medifast (MED) Projected to Post Quarterly Earnings on Tuesday
Medifast (NYSE:MED) will be releasing earnings after the market closes on Tuesday, February 18, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=662325)
Medifast, Inc. stock logo
JPMorgan Chase & Co. Boosts Holdings in Medifast, Inc. (NYSE:MED)
JPMorgan Chase & Co. lifted its position in Medifast, Inc. (NYSE:MED - Free Report) by 156.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 57,455 shares of the specialty retailer's stock after purchasing an additional 35,017 shares
Medifast, Inc. stock logo
Geode Capital Management LLC Has $4.68 Million Stock Holdings in Medifast, Inc. (NYSE:MED)
Geode Capital Management LLC trimmed its stake in shares of Medifast, Inc. (NYSE:MED - Free Report) by 12.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 244,482 shares of the specialty
Medifast, Inc. stock logo
Jane Street Group LLC Reduces Holdings in Medifast, Inc. (NYSE:MED)
Jane Street Group LLC reduced its position in shares of Medifast, Inc. (NYSE:MED - Free Report) by 38.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 161,089 shares of the special
3 Consumer Stocks to Drop Right Now
Medifast, Inc. stock logo
Charles Schwab Investment Management Inc. Trims Position in Medifast, Inc. (NYSE:MED)
Charles Schwab Investment Management Inc. trimmed its holdings in Medifast, Inc. (NYSE:MED - Free Report) by 15.6% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 148,236 shares of the specialty retailer's stock after selling 27,336 shares during the perio
Medifast, Inc. stock logo
Hotchkis & Wiley Capital Management LLC Has $5.64 Million Stock Holdings in Medifast, Inc. (NYSE:MED)
Hotchkis & Wiley Capital Management LLC cut its holdings in Medifast, Inc. (NYSE:MED - Free Report) by 8.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 294,880 shares of the specialty retailer's stock after selling 28,000 shares during the quarter. Hotch
Remove Ads
Get Medifast News Delivered to You Automatically

Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

MED Media Mentions By Week

MED Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MED
News Sentiment

1.06

0.80

Average
Consumer Staples
News Sentiment

MED News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MED Articles
This Week

10

3

MED Articles
Average Week

Remove Ads
Get Medifast News Delivered to You Automatically

Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:MED) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners